0.415

+0.021 (+5.33%)
Range 0.409 - 0.430   (5.13%)
Open 0.430
Previous Close 0.394
Buy Price 0.320
Buy Volume -
Sell Price 0.321
Sell Volume -
Volume 2,885,917
Value -
Remark
Measurement Type Value
EPS (USD) -0.316
Trailing EPS (USD) -0.52
NAV (USD) 0.05
Cash In Hand (USD) 0.204
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 8.298
Price / Cash In Hand 2.036
Issued & Paid-up Shares 75,194,100
Treasury Shares -
Market Cap (M) 20.444
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
ISIN Code
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 28 Nov 2020 02:00.
Data powered by
View All Events

About ORAGENICS INC

Oragenics, Inc. is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits. The Company is developing and seeking partners or commercializing four products, including ProBiora3, LPT3-04, SMaRT Replacement Therapy and MU1140-S. The Company is focusing its efforts on growing its oral probiotic business both with its branded Evora products and through licensing and private label sales (with ProBiora3). Its SMaRT Replacement Therapy is designed to be a treatment applied to the teeth that has the potential to offer protection against dental caries, or tooth decay.

Loading Chart...